Received: 9 August 2016
Accepted: 10 March 2017
First Online: 10 April 2017
: G.R.F. has received grants from, consulted for, has been a speaker at or has been on the advisory board of AbbVie, Alcura, Bristol-Myers Squibb, Gilead, Janssen, GlaxoSmithKline, Merck, Roche, Springbank, Idenix, Tekmira and Novartis. G.M. is a partner in Peptide Groove LLP, which commercializes the HLA*IMP software used for HLA imputation.
Free to read: This content has been made available to all.